91 related articles for article (PubMed ID: 6304572)
21. Autoimmunity to collagen in human lung cancer.
Fernandez-Madrid F; Karvonen RL; Kraut MJ; Czelusniak B; Ager JW
Cancer Res; 1996 Jan; 56(1):121-6. PubMed ID: 8548751
[TBL] [Abstract][Full Text] [Related]
22. Anti-nuclear, anti-mitochondrial, anti-smooth muscle and anti-parietal cell antibodies in the healthy Malaysian population.
Azizah MR; Shahnaz M; Zulkifli MN; Nasuruddin BA
Malays J Pathol; 1995 Dec; 17(2):83-6. PubMed ID: 8935131
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies in patients with bronchial carcinoma.
Hodson ME; Turner-Warwick M
Thorax; 1975 Aug; 30(4):367-70. PubMed ID: 170702
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies versus clinical symptoms in blood donors.
Vrethem M; Skogh T; Berlin G; Ernerudh J
J Rheumatol; 1992 Dec; 19(12):1919-21. PubMed ID: 1294740
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence of autoantibodies in serum of healthy persons over 85 years of age].
Potocka-Płazak K; Pituch-Noworolska A; Kocemba J
Przegl Lek; 1995; 52(11):544-6. PubMed ID: 8834631
[TBL] [Abstract][Full Text] [Related]
26. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
27. The detection of quantitative serum p53 protein in lung cancer.
Sen E; Gönüllü U; Akar N
Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
[TBL] [Abstract][Full Text] [Related]
28. [Use of monoclonal antibodies for immunodiagnosis of lung cancer].
Romanova RI; Gergert VI; Filippov VP; Goncharskaia MA; Evgushchenko GV; Sidorova NF; Gorelova LA
Probl Tuberk; 1997; (5):44-8. PubMed ID: 9454255
[TBL] [Abstract][Full Text] [Related]
29. [Is there a relationship between the presence of autoantibodies or mixed cryoglobulinemia and the clinical and histological characteristics of chronic viral hepatitis C?].
Rolachon A; Pasquier D; Girard M; Arvieux J; Bichard P; Bensa JC; Zarski JP
Gastroenterol Clin Biol; 1994; 18(3):251-6. PubMed ID: 7926441
[TBL] [Abstract][Full Text] [Related]
30. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
[TBL] [Abstract][Full Text] [Related]
31. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
Gregorio GV; Choudhuri K; Ma Y; Vegnente A; Mieli-Vergani G; Vergani D
J Immunol; 1999 Feb; 162(3):1802-10. PubMed ID: 9973445
[TBL] [Abstract][Full Text] [Related]
32. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma.
Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM
Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
[TBL] [Abstract][Full Text] [Related]
34. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
[TBL] [Abstract][Full Text] [Related]
35. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
36. P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
Bergqvist M; Brattström D; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Wagenius G; Brodin O
Anticancer Res; 1998; 18(3B):1999-2002. PubMed ID: 9677456
[TBL] [Abstract][Full Text] [Related]
37. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls.
Laske C; Zank M; Klein R; Stransky E; Batra A; Buchkremer G; Schott K
Psychiatry Res; 2008 Feb; 158(1):83-6. PubMed ID: 18096244
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
40. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
